Geode Capital Management’s Moleculin Biotech MBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.31K | Buy |
|
|||||
|
2025
Q1 | $25.4K | Buy |
|
|||||
|
2024
Q4 | $37.5K | Buy |
|
|||||
|
2024
Q3 | $62K | Buy |
|
|||||
|
2024
Q2 | $69K | Buy |
|
|||||
|
2024
Q1 | $98.2K | Buy |
|
|||||
|
2023
Q4 | $212K | Hold |
|
|||||
|
2023
Q3 | $105K | Buy |
|
|||||
|
2023
Q2 | $143K | Hold |
|
|||||
|
2023
Q1 | $237K | Hold |
|
|||||
|
2022
Q4 | $261K | Sell |
|
|||||
|
2022
Q3 | $261K | Hold |
|
|||||
|
2022
Q2 | $358K | Buy |
|
|||||
|
2022
Q1 | $437K | Hold |
|
|||||
|
2021
Q4 | $456K | Hold |
|
|||||
|
2021
Q3 | $736K | Buy |
|
|||||
|
2021
Q2 | $871K | Buy |
|
|||||
|
2021
Q1 | $713K | Buy |
|
|||||
|
2020
Q4 | $234K | Buy |
|
|||||
|
2020
Q3 | $193K | Buy |
|
|||||
|
2020
Q2 | $219K | Buy |
|
|||||
|
2020
Q1 | $77K | Hold |
|
|||||
|
2019
Q4 | $115K | Hold |
|
|||||
|
2019
Q3 | $140K | Hold |
|
|||||
|
2019
Q2 | $158K | Hold |
|
|||||
|
2019
Q1 | $102K | Hold |
|
|||||
|
2018
Q4 | $131K | Hold |
|
|||||
|
2018
Q3 | $202K | Hold |
|
|||||
|
2018
Q2 | $226K | Buy |
|
|||||
|
2018
Q1 | $154K | Hold |
|
|||||
|
2017
Q4 | $159K | Buy |
|
|||||
|
2017
Q3 | $140K | Hold |
|
|||||
|
2017
Q2 | $110K | Buy |
|